Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.61 |
| ▸ | MMP3 | P08254 | 12/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | USP5 | P45974 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6590105 | 1.00 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6590102 | 1.00 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6588092 | 0.93 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6588095 | 0.93 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6588097 | 0.93 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6587795 | 0.91 | MMP2 (0.65) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6587788 | 0.91 | MMP2 (0.65) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6587784 | 0.91 | MMP2 (0.65) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6588492 | 0.87 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 | |
| SCHEMBL6588498 | 0.87 | MMP2 (0.61) | MMP2MMP3L3MBTL1NAMPTUSP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |